" /> Satraplatin - CISMeF





Preferred Label : Satraplatin;

NCIt synonyms : (OC-6-43)-bis(acetato)amminedichloro(cyclohexylamine)platinum; (OC-6-43)-bis(acetato-O)amminedichloro(cyclohexanamine)platinum; platinum,bis(acetato-O)amminedichloro(cyclohexanamine)-,(OC-6-43);

NCIt related terms : BMS-182751; JM 216;

NCIt definition : An orally administered third generation platinum compound with potential antineoplastic activity. Satraplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups in DNA, inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in cell growth inhibition and apoptosis.;

Alternative definition : NCI-GLOSS: A substance being studied in the treatment of prostate and other types of cancer. It contains the metal platinum and may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent.;

UNII : 8D7B37T28G;

InChIKey : QFDCPOONOIIAOS-UHFFFAOYSA-J;

CAS number : 129580-63-8;

Drug name : Orplatna;

Molecule name : BMY-45594; JM-216;

Chemical formula : C6H13N.2C2H3O2.2Cl.Pt.H3N;

Codes from synonyms : CDR0000367461; CDR0000045425; CDR0000367462;

Détails


Position du mot-clé dans l'(les) arborescence(s) : arborescence

Vous pouvez consulter :


Nous contacter.
31/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.